DPA
AMGN icon

Delphi Private Advisors’s Amgen AMGN Stock Holding History

Delphi Private Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-89
Closed -$13K – 104
2016
Q4 		$13K Sell
89
-29
-25% -$4.37K 0.02% 89
2016
Q3 		$20K Sell
118
-37
-24% -$6.26K 0.03% 64
2016
Q2 		$24K Buy
155
+20
+15% +$3.11K 0.04% 77
2016
Q1 		$20K Sell
135
-49
-27% -$7.28K 0.04% 96
2015
Q4 		$30K Buy
+184
New +$28.9K 0.05% 76

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Delphi Private Advisors's AMGN Position: Q1 2017 in Review

Delphi Private Advisors sold out of Amgen (AMGN) in Q1 2017, closing a stake of 89 shares — an estimated $13K sold.

Delphi Private Advisors first reported a position in AMGN in Q4 2015 and held it in 5 quarters. The position peaked at $30K in Q4 2015. 1,600 funds tracked by Wall St. Rank hold AMGN as of Q1 2017.

  • Delphi Private Advisors reported no remaining Amgen position as of Q1 2017 after selling out during the quarter.
  • Delphi Private Advisors sold 89 Amgen shares in Q1 2017, an estimated $13K.
  • Delphi Private Advisors first reported a position in Amgen in Q4 2015 and held it in 5 quarters.
  • Delphi Private Advisors's Amgen position peaked at $30K in Q4 2015.
  • 1,600 funds tracked by Wall St. Rank held Amgen as of Q1 2017.

Based on Delphi Private Advisors's 13F filing for Q1 2017, filed 25 Apr 2017.